Applications of (S)-3-Amino-4-(3-Benzothienyl)Butanoic Acid Hydrochloride in Industrial Manufacturing

As a leading manufacturer of (S)-3-Amino-4-(3-Benzothienyl)Butanoic Acid Hydrochloride, we support our partners in multiple specialized sectors, focusing on their unique production requirements, integration steps, and strict regulatory needs. Below are core industrial applications based on real downstream manufacturing flows.

1. Pharmaceutical Intermediates for Antiepileptic APIs

This compound acts as a crucial chiral intermediate in the synthesis of certain antiepileptic active pharmaceutical ingredients, particularly for drugs within the gabapentinoid class. Leading pharmaceutical producers incorporate it during their multi-stage chemical synthesis workflows to achieve high enantiopurity. Direct input occurs prior to amide bond formation, which is critical for maintaining stereochemical integrity in the finished API. Secure sourcing of this intermediate directly impacts regulatory compliance audits, batch release quality, and supply continuity for the final medicine.

Industry compliance standards

• ICH Q7 GMP for active pharmaceutical ingredient manufacturing
• United States Pharmacopeia (USP) monographs where applicable
• European Pharmacopoeia (Ph. Eur.) for related synthetic steps
• 21 CFR 210/211 for US pharmaceutical manufacturing

Typical usage ratio

• Used at a 1:1 stoichiometric molar amount relative to the desired target API intermediate; adjustment occurs based on process yield and purification step requirements.

Downstream process integration

• Charged into the enantioselective synthesis sequence post-hydrolysis and prior to cyclization or amidation steps.
• Handled in a controlled area to avoid cross-contamination.

Final product types

• Gabapentinoid-based API finished substances
• Bulk pharmaceutical intermediates for further pharmaceutical processing
• Stabilized oral solid dose drug products

2. Research Reagents for Central Nervous System (CNS) Studies

Many academic and industry laboratories rely on this material for receptor binding assays, transporter activity screening, and discovery work in neuropharmacology. The molecule's structural similarity to established GABA analogs makes it a reference compound for drug mode-of-action studies or as a scaffold in medicinal chemistry programs. Researchers typically utilize high-purity grades to minimize experimental variability and satisfy institutional research review requirements.

Industry compliance standards

• OECD Good Laboratory Practice (GLP) for regulated studies
• ISO 9001:2015 for laboratory reagent manufacturing and QC
• Institutional IACUC or IRB guidelines for in vivo use
• Material transfer agreements (MTA) covering intellectual property use

Typical usage ratio

• Diluted to a 10–100 µM concentration in in vitro pharmacology screens; adjusted based on assay endpoint and cell model.

Downstream process integration

• Dissolved in buffer or assay medium for direct application in CNS receptor/transporter studies.
• Blended within custom bioassay kits provided to external research clients.

Final product types

• Neurochemical assay kits for university and pharmaceutical laboratories
• Reference standards for CNS receptor modeling
• Reagent bottles supplied for academic neuroscience research

3. Building Block in Chiral Fine Chemical Synthesis

Producers of high-value chiral fine chemicals employ this molecule as a core building block, especially where the benzothienyl moiety supports the synthesis of advanced intermediates in agrochemical or specialty pharmaceutical sectors. Manufacturers favor batches with controlled particle size and strictly verified enantiomeric purity to ensure synthetic step reliability. Entry occurs during multi-step organic insertions or functional group modifications conducted in high-performance reactors.

Industry compliance standards

• ISO 9001:2015 and ISO 14001:2015 for chemical production and environmental management
• REACH registration for EU market transfer of fine chemicals
• Regional chemical hazard communication programs (e.g., GHS/CLP)

Typical usage ratio

• Integrated at 5–12% by total stepwise reactant mass; amounts vary by synthetic pathway and target chiral intermediate molecule.

Downstream process integration

• Dosed directly into chiral coupling reactions or aromatic substitution processes under inert atmospheric controls.
• Quality-monitored via chiral HPLC and NMR after introduction to ensure no racemization.

Final product types

• Pharmaceutical-grade chiral fine chemicals
• Agrochemical pre-cursors for advanced active substances
• Specialty monomers for research-scale polymerization

4. Reference Standard in Analytical and Stability Testing

Quality control and analytical laboratories at pharmaceutical and fine chemical plants use this material as a reference for developing and validating analytical methods, especially during chiral purity and impurity profiling of related drug substances. The material's crystalline hydrochloride form ensures high lot-to-lot consistency and reliable baseline readings in HPLC, LC-MS, and chiral chromatographic assays. Accurate quantification with this standard supports regulatory submissions and product release protocols.

Industry compliance standards

• USP General Chapter <1225> for Analytical Method Validation
• Ph. Eur. 2.2.46 for chromatographic separation validation
• FDA Guidance for Industry: Analytical Procedures and Methods Validation
• ICH Q2(R2) for analytical method validation

Typical usage ratio

• Applied at 0.1–1 mg/mL reference concentration for method set-up and precision testing; adjusted per instrument sensitivity and sample matrix.

Downstream process integration

• Used for establishing calibration curves in HPLC and chiral chromatography.
• Periodically verified as part of QC system suitability and stability studies on finished APIs and intermediates.

Final product types

• Pharmaceutical bulk substance quality dossiers
• Analytical kits for GMP-compliant manufacturing
• Internal reference sample libraries